Literature DB >> 12010211

Reading speed test for potential central vision measurement.

Konrad Pesudovs1, Bhavesh Patel, John A Bradbury, David B Elliott.   

Abstract

This study examines the validity and reliability of a reading speed test as a measure of potential central vision. Reading speed was calculated in words per minute (wpm) from the time taken to read 30 words of 1.20 logMAR size text. Scores were obtained from subjects with cataract (n = 48), macular disease(n = 35), peripheral vision loss(n = 14) and normal eyes (n = 10). Subjects with macular disease (27.0 +/- 13.2 wpm) read much slower than subjects with cataract (91.9 +/- 13.6 wpm). Little difference was found between subjects with cataract, peripheral vision loss (91.5 +/- 14.7 wpm)and normal eyes (103.8 +/- 15.5 wpm). Repeat testing gave values within +/- 16% of reading speed. These results suggest that a reading speed test using large text could be useful as a potential central vision test in cataract patients.

Entities:  

Mesh:

Year:  2002        PMID: 12010211     DOI: 10.1046/j.1442-9071.2002.00522.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  3 in total

1.  Reliability of a standardized reading chart system: variance component analysis, test-retest and inter-chart reliability.

Authors:  Eva Stifter; Franz König; Thomas Lang; Peter Bauer; Sibylla Richter-Müksch; Michaela Velikay-Parel; Wolfgang Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-10       Impact factor: 3.117

2.  Predictions of postoperative visual outcome in subjects with cataract: a preoperative and postoperative study.

Authors:  William A Douthwaite; Marta Vianya-Estopà; David B Elliott
Journal:  Br J Ophthalmol       Date:  2006-11-23       Impact factor: 4.638

3.  Differences in reading performance of patients with Drusen maculopathy and subretinal fibrosis after CNV.

Authors:  Sibylla Richter-Mueksch; Michael Stur; Eva Stifter; Wolfgang Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-27       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.